Digg It - Business

The year 2004 was an exceptional one for the European Union (EU) with the historic enlargement to include ten new member states and the signat

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ure in Rome of the Treaty establishing for the first time an EU Constitution. That momentum continued into the first half of 2005, marked by t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

he beginning of the ratification process for the European Constitution.

The results of the various ratification processes of the proposed EU

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Constitution, either through parliament or via a referendum, have varied from one country to another. The European Union has to go through a E

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

uropean context that has proven to be both eventful and tense over the last few months. In line with the post French and Dutch referenda studi

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

es, European citizens appear today to be more critical in their analysis of the European Union, without however calling into question either t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

heir membership, or the European construction itself. Nevertheless, certain indicators from the recent Eurobarometer survey (fall 2005) reveal

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

significant changes in views and highlight just how necessary it is to bring European citizens and European institutions closer together. Thu

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

s, the focus is now on how the European Union will reach successfully its citizens and under which conditions this attempt will be more effect

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ive.

Under this notion, it is interesting to consider the unquestionable fact that the Internet is changing the world we live in. It is a cha

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ge no less significant than the Industrial Revolution of the 18th and 19th centuries. Over the last two decades, information technologies and

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

the Internet have been transforming the way companies do business, the way students learn, the way scientists carry out research and the way i

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

n which governments provide services to their citizens. In fact, ICTs have managed over the last decade to become the main message vehicles of

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

the modern societies' communication systems. Corporations and governments, upon realizing their immense capabilities, are using contemporary

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ICTs to disseminate messages, address issues, and ultimately influence public opinion.

Living today in the Information Age and as Internet us

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ers worldwide are increasing in numbers, organizations like the EU wish to influence the citizens' public opinion using the new digital medium

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

's unique communications capabilities. But any kind of state will not achieve a strong, competitive economy simply by incorporating digital te

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

chnologies into manufacturing or services. It also needs highly skilled workers to operate the new systems, and digitally literate consumers t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

o buy the new goods and services. That means training and education for people of all ages. Thus, competitiveness depends on how much the sta

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

te invests in its people. The EU member states will soon have to prove their proactive thinking and their policies effectiveness on the matter

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/2358/diggit-Fostering-Change-In-European-Union.html">Fostering Change In European Union</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/2358/diggit-Fostering-Change-In-European-Union.html]Fostering Change In European Union[/url]

By starting with the best foundation; great looking and flexible retail store displays and retail store shelving, retailers can design and build great looking displays for their product that will help sell their products to their customers. By consistently reinforcing the perceived need for the item today's retailer can create a winning store environment that the customer will want to return to over and over again.

As a newbee to eBay I sold a LOT of things. I looked around our farm and I found a TON of stuff that I was interested in getting rid of. Old metals, seeds, wood, cattle, dogs, wife - (well, truth is she got rid of me first, but that's another story)...

Laser pointers are useful when used at a business meeting to point out areas of interest on a chart or graph, and very amusing when the kitty chases them around the floor. But, innocuous as they seem, even the weakest of laser pointers can do damage if the eye is exposed to them directly for a length of time.

Tags

Links

Digg It - Fostering Change In European Union

Related Articles: